The impact of selective use of prophylactic indomethacin on the incidence of severe intraventricular hemorrhage in a tertiary care NICU
Monday, May 1, 2023
9:00 AM – 9:15 AM ET
Location: Convention Center: 145 AB
Publication Number: 3130.5
Sasha Harrison, Brigham and Women's Hospital, New York, NY, United States; Eniko Szakmar, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Budapest, Budapest, Hungary; Hoda El-Shibiny, BWH, Boston, MA, United States; Chelsea Munster, Brigham and Women's Hospital, 731 South Eureka St, CA, United States; Tina Steele, Brigham and Women's Hospital, North Billerica, MA, United States; Mohamed El-Dib, Harvard Medical School, Boston, MA, United States
Presenting Author(s)
Sasha Harrison (she/her/hers)
Trainee Brigham and Women's Hospital New York, New York, United States
Disclosure(s):
Sasha Harrison: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Eniko Szakmar, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Hoda Elshibiny, BS Pharm, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Chelsea Munster, BA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tina Steele, RN, IBCLC: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mohamed El-Dib, MD: Medtronic (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Radiometer (Terminated, February 1, 2022) (Products/Services: Advisory Committee)